1. Home
  2. INDP vs BON Comparison

INDP vs BON Comparison

Compare INDP & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • BON
  • Stock Information
  • Founded
  • INDP 2000
  • BON 2006
  • Country
  • INDP United States
  • BON China
  • Employees
  • INDP N/A
  • BON N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • BON Medicinal Chemicals and Botanical Products
  • Sector
  • INDP Health Care
  • BON Health Care
  • Exchange
  • INDP Nasdaq
  • BON Nasdaq
  • Market Cap
  • INDP 6.0M
  • BON 5.9M
  • IPO Year
  • INDP N/A
  • BON 2021
  • Fundamental
  • Price
  • INDP $12.87
  • BON $1.52
  • Analyst Decision
  • INDP Strong Buy
  • BON
  • Analyst Count
  • INDP 2
  • BON 0
  • Target Price
  • INDP $238.00
  • BON N/A
  • AVG Volume (30 Days)
  • INDP 701.1K
  • BON 1.3M
  • Earning Date
  • INDP 08-11-2025
  • BON 07-15-2025
  • Dividend Yield
  • INDP N/A
  • BON N/A
  • EPS Growth
  • INDP N/A
  • BON N/A
  • EPS
  • INDP N/A
  • BON 4.17
  • Revenue
  • INDP N/A
  • BON $23,844,556.00
  • Revenue This Year
  • INDP N/A
  • BON $223.38
  • Revenue Next Year
  • INDP N/A
  • BON $18.82
  • P/E Ratio
  • INDP N/A
  • BON $0.36
  • Revenue Growth
  • INDP N/A
  • BON N/A
  • 52 Week Low
  • INDP $7.56
  • BON $1.14
  • 52 Week High
  • INDP $66.64
  • BON $73.75
  • Technical
  • Relative Strength Index (RSI)
  • INDP 57.62
  • BON 48.52
  • Support Level
  • INDP $9.45
  • BON $1.33
  • Resistance Level
  • INDP $11.71
  • BON $1.57
  • Average True Range (ATR)
  • INDP 2.20
  • BON 0.14
  • MACD
  • INDP 0.24
  • BON 0.05
  • Stochastic Oscillator
  • INDP 43.00
  • BON 80.05

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About BON Bon Natural Life Limited

Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.

Share on Social Networks: